Clinica Romero Oscar is categorized under Doctors in Los Angeles, CA and active since 1983.
Clinica Romero Oscar was established in 1983, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Albert Pacheco, Executive Director at the company’s single location by writing to 123 South Alvarado St, Los Angeles, California CA 90057 or by phoning (213) 989-7700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinica Romero Oscar |
| Contact Person: | Albert Pacheco, Executive Director |
| Address: | 123 South Alvarado St, Los Angeles, California 90057 |
| Phone Number: | (213) 989-7700 |
| Website Address: | clinicaromero.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1983 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Clinica Romero Oscar was started in 1983 to provide professional Doctors under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Albert Pacheco, Executive Director for inquiries that concern Clinica Romero Oscar by calling the company number (213) 989-7700, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinica Romero Oscar can be found at the coordinates 34.06593,-118.27083 as well as the street address 123 South Alvarado St in Los Angeles, California 90057.
For its online presence, you may visit Clinica Romero Oscar’s website at clinicaromero.com and engage with its social media outlets through on Twitter and on Facebook.